{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:29:28Z","timestamp":1791473368822,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejogrb.2013.05.019","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T09:15:39Z","timestamp":1372151739000},"page":"157-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome"],"prefix":"10.1016","volume":"170","author":[{"given":"Sezai","family":"Sahmay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Atakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Oncul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Tuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begum","family":"Aydogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Seyisoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.05.019_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for M\u00fcllerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ydbio.2003.10.009","article-title":"Oocyte regulation of anti-M\u00fcllerian hormone expression in granulosa cells during ovarian follicle development in mice","volume":"266","author":"Salmon","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Anti-M\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0020","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-Mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12522-010-0066-1","article-title":"Serum anti-M\u00fcllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients","volume":"10","author":"Sahmay","year":"2011","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","article-title":"Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles","volume":"28","author":"Ocal","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0035","doi-asserted-by":"crossref","first-page":"e34290","DOI":"10.1371\/journal.pone.0034290","article-title":"Follicle stimulating hormone and anti-M\u00fcllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study","volume":"7","author":"Weghofer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0040","first-page":"11","article-title":"Serum anti-M\u00fcllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF\/ICSI cycles","author":"Sahmay","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0050","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0055","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2005.02.052","article-title":"Serum M\u00fcllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome","volume":"84","author":"Siow","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0065","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum anti-M\u00fcllerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0070","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/deg115","article-title":"Ultrasound examination of polycystic ovaries: is it worth counting the follicles?","volume":"18","author":"Jonard","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0075","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/humrep\/den015","article-title":"The relationship between anti-M\u00fcllerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome","volume":"23","author":"Chen","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1530\/EJE-08-0510","article-title":"Anti-M\u00fcllerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome","volume":"160","author":"Diamanti-Kandarakis","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0090","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-M\u00fcllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0095","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-M\u00fcllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/humrep\/dei499","article-title":"Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-M\u00fcllerian hormone","volume":"21","author":"Fleming","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0105","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"ESHRE Special Interest Group for Reproductive Endocrinology-AMH Round Table. Anti-M\u00fcllerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0115","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/humrep\/den185","article-title":"Anti-M\u00fcllerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome","volume":"23","author":"Das","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Anti-M\u00fcllerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil Streil"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called hyperthecosis","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","article-title":"Anti-M\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries","volume":"98","author":"Rosenfield","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0140","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.05.019_bib0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1095\/biolreprod.104.039362","article-title":"Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells","volume":"73","author":"Hickey","year":"2005","journal-title":"Biol Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513002509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513002509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:13Z","timestamp":1759555813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211513002509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0301211513002509"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.05.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}